For research use only. Not for therapeutic Use.
Emivirine(Cat No.:M102476)is a non-nucleoside reverse transcriptase inhibitor (NNRTI) developed for the treatment of HIV-1 infections. It binds directly to reverse transcriptase, causing conformational changes that block viral RNA-dependent DNA polymerase activity, thereby inhibiting viral replication. Emivirine exhibits potent antiviral activity with a favorable resistance profile and low toxicity, making it a valuable compound in antiretroviral research. Although not widely used clinically, Emivirine remains significant for studying NNRTI mechanisms, resistance pathways, and the development of novel therapies to manage HIV infections effectively.
Catalog Number | M102476 |
CAS Number | 149950-60-7 |
Molecular Formula | C17H22N2O3 |
Purity | ≥95% |
Target | HIV |
Storage | Store at -20°C |
IUPAC Name | 6-benzyl-1-(ethoxymethyl)-5-propan-2-ylpyrimidine-2,4-dione |
InChI | InChI=1S/C17H22N2O3/c1-4-22-11-19-14(10-13-8-6-5-7-9-13)15(12(2)3)16(20)18-17(19)21/h5-9,12H,4,10-11H2,1-3H3,(H,18,20,21) |
InChIKey | MLILORUFDVLTSP-UHFFFAOYSA-N |
SMILES | CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2 |
Reference | </br>1:Synthesis and Antiviral Evaluation of 1-[(2-Phenoxyethyl)oxymethyl] and 6-(3,5-Dimethoxybenzyl) Analogues of HIV Drugs Emivirine and TNK-651. El-Brollosy NR, Loddo R.Drug Res (Stuttg). 2016 Apr;66(4):181-8. doi: 10.1055/s-0035-1559683. Epub 2015 Aug 27. PMID: 26313923 </br>2:Synthesis and antiviral evaluation of 6-(trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of HIV drugs emivirine and GCA-186. El-Brollosy NR, Sørensen ER, Pedersen EB, Sanna G, La Colla P, Loddo R.Arch Pharm (Weinheim). 2008 Jan;341(1):9-19. PMID: 18161905 </br>3:Chemo- and regioselective functionalization of uracil derivatives. Applications to the synthesis of oxypurinol and emivirine. Boudet N, Knochel P.Org Lett. 2006 Aug 17;8(17):3737-40. PMID: 16898805 </br>4:Synthesis and evaluation of double-prodrugs against HIV. Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)-type reverse transcriptase inhibitors via the SATE prodrug approach. Petersen L, Jørgensen PT, Nielsen C, Hansen TH, Nielsen J, Pedersen EB.J Med Chem. 2005 Feb 24;48(4):1211-20. PMID: 15715487 </br>5:Synthesis of furoannelated analogues of Emivirine (MKC-442). Wamberg M, Pedersen EB, Nielsen C.Arch Pharm (Weinheim). 2004 Mar;337(3):148-51. PMID: 15038059 </br>6:Synthesis of 6-arylvinyl analogues of the HIV drugs SJ-3366 and Emivirine. Wamberg M, Pedersen EB, El-Brollosy NR, Nielsen C.Bioorg Med Chem. 2004 Mar 1;12(5):1141-9. PMID: 14980626 </br>7:Multiple pathways in the synthesis of new annelated analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (emivirine). Therkelsen FD, Hansen AL, Pedersen EB, Nielsen C.Org Biomol Chem. 2003 Aug 21;1(16):2908-18. PMID: 12968341 </br>8:Three-drug combinations of emivirine and nucleoside reverse transcriptase inhibitors in vitro: long-term culture of HIV-1-infected cells and breakthrough viruses. Nitanda T, Wang X, Somekawa K, Yuasa S, Baba M.Antivir Chem Chemother. 2001 May;12(3):161-7. PMID: 12959324 </br>9:Synthesis of novel N-1 (allyloxymethyl) analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine) with improved activity against HIV-1 and its mutants. El-Brollosy NR, Jørgensen PT, Dahan B, Boel AM, Pedersen EB, Nielsen C.J Med Chem. 2002 Dec 19;45(26):5721-6. PMID: 12477355 </br>10:Emivirine: an NRTI that functions as an NNRTI. Cheonis N.BETA. 1999;12(4):7-8. PMID: 11367264 |